Ellen T. Chang

Amgen Inc.

Public scientific profile · Unclaimed

Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.

Top expertise

  • Global Cancer Incidence and Screening

    Strong evidence · 5 supporting papers · latest 2025

  • Lung Cancer Diagnosis and Treatment

    Strong evidence · 2 supporting papers · latest 2025

  • Head and Neck Cancer Studies

    Strong evidence · 1 supporting paper · latest 2025

  • Colorectal Cancer Screening and Detection

    Strong evidence · 3 supporting papers · latest 2025

  • Diabetes Treatment and Management

    Strong evidence · 1 supporting paper · latest 2026

  • Protein Degradation and Inhibitors

    Solid evidence · 1 supporting paper · latest 2025

  • Peptidase Inhibition and Analysis

    Solid evidence · 1 supporting paper · latest 2025

  • CAR-T cell therapy research

    Solid evidence · 1 supporting paper · latest 2025

Publications (15)

  • PROTACs in cancer immunotherapy: a minireview

    2025DOIPMID 41032705

  • Estimated proportion of cancer deaths not addressed by current cancer screening efforts in the United States

    2025DOIPMID 40109213

  • Overall and non‐lung cancer incidence and mortality in the National Lung Screening Trial: Opportunities for multi‐cancer early detection

    2024DOI

  • Population-based nasopharyngeal carcinoma survival in southern China

    2025DOIPMID 41152602

  • Real-world Weight Change at 6 and 12 Months After Glucagon-Like Peptide-1-Based Treatment Initiation by Duration of Use and Drug Type

    2026DOI

  • Estimating the Burden of False Positives and Implementation Costs From Adding Multiple Single Cancer Tests or a Single Multi‐Cancer Test to Standard‐Of‐Care Screening

    2025DOIPMID 40095751

  • Strong association between reduction of late-stage cancers and reduction of cancer-specific mortality in meta-regression of randomized screening trials across multiple cancer types

    2024DOIPMID 38797981

  • Abstract 6075: Most cancer deaths are unaddressed by current screening paradigms

    2024DOI

  • Increasing prevalence of obesity among US adults from 1999 to 2023, data from the US National Health and Nutrition Examination Survey (NHANES)

    2026DOI

  • Injury-Activated ERMs Undergo EMT and May Contribute to Periodontal Repair

    2025DOIPMID 41408679

  • 995MO Association of SARS-COV-2 mRNA vaccines with tumor PD-L1 expression and clinical responses to immune checkpoint blockade

    2024DOI

  • Intentional Self-Harm Mortality Among 15- to 24-Year-Olds in Asian American Subgroups, 2011-2020

    2024DOI

  • 0820 Challenges to Pediatric Patients Sleeping Well in the Hospital: Environmental and Practice Considerations

    2024DOI

  • More than an Amide Bioisostere: Discovery of 1,2,4-Triazole-containing Pyrazolo[1,5-a]pyrimidine Host CSNK2 Inhibitors for Combatting β-Coronavirus Replication

    2024DOI

  • Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

    2024DOI

Organizations in sourced records

Affiliation evidence only — not confirmed current employment.

  • Amgen Inc.

Source: OpenAlex · retrieved 2026-09-29

Are you Ellen T. Chang? Sign in to claim this profile